Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Y9PZ
|
||||
| Former ID |
DIB010812
|
||||
| Drug Name |
Efungumab
|
||||
| Synonyms |
Mycograb; Hsp90 mAb; Myc-123C28Y; Hsp90 mAb (cancer), NeuTec; Hsp90 mAb (Candida albicans infection/Cryptococcus neoformans meningitis), NeuTec
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Breast cancer [ICD9: 174, 175; ICD10:C50] | Phase 2 | [522586] | ||
| Company |
University of Manchester
|
||||
| CAS Number |
CAS 762260-74-2
|
||||
| Target and Pathway | |||||
| Target(s) | Heat shock protein HSP90 | Target Info | [530401] | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.